Option Care Health (OPCH)
(Delayed Data from NSDQ)
$27.56 USD
-0.33 (-1.18%)
Updated Sep 16, 2025 04:00 PM ET
Pre-Market: $28.94 +1.38 (5.01%) 8:56 AM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
OPCH 27.56 -0.33(-1.18%)
Will OPCH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for OPCH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPCH
Option Care (OPCH) Surpasses Q2 Earnings and Revenue Estimates
BTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now?
OPCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?
BrightSpring Soars to All-Time High on Quality Strength: Still a Buy?
Option Care (OPCH) is an Incredible Growth Stock: 3 Reasons Why
Other News for OPCH
Option Care Health (OPCH) Shares Rise on Positive Market Insights
Option Care Health up 5% at $29 per share following positive Barron’s note
Option Care Health shares ‘undervalued’, says Barron’s
Option Care Health up 5% at $29 per share following positive Barron's note
Option Care Health shares 'undervalued', says Barron's